Medicinal Chemistry Research

, Volume 26, Issue 10, pp 2452–2467 | Cite as

Studies on new urease inhibitors by using biochemical, STD-NMR spectroscopy, and molecular docking methods

  • Jalaluddin A. Khan
  • Atia-tul- Wahab
  • Sumaira Javaid
  • Maryam AL-Ghamdi
  • Etimad Huwait
  • Muniza Shaikh
  • Amsal Shafqat
  • M. Iqbal ChoudharyEmail author
Original Research


Discovery of new urease inhibitors is an important approach towards the treatment of diseases caused by ureolytic bacteria. Urease has an important role in several pathologies, such as urolithiasis, peptic and duodenal ulcers, etc. In this regard, urease inhibitory activity of heterocyclic synthetic compounds 114, belonging to different chemical classes was evaluated by employing in vitro biochemical assay, and saturation transfer difference-NMR technique. Compounds 1, 3–5, 7, 10, and 12 have shown urease inhibitory potential in vitro. Among them, compound 1 was found to be more potent (IC50 of 12.90 ± 0.63 µM) than a clinical drug, acetohydroxamic acid (IC50 = 41.5 ± 1.50 µM) (Standard). Compounds 3 (IC50 = 15.0 ± 1.10 µM), 4 (IC50 = 24.67 ± 2.87 µM), and 5 (IC50 = 25.50 ± 0.63 µM) were also identified as potent inhibitors of urease enzyme. These compounds showed strong interactions with the urease enzyme (receptor) in saturation transfer difference-NMR spectra. Specifically, aromatic protons of active compounds received maximum Rf saturation from the receptor protein, thus were inferred to be as in close proximity to the protein. New inhibitors identified through biochemical assay and saturation transfer difference-nuclear magnetic resonance techniques were then subjected to kinetic and molecular docking studies to investigate their mode of inhibition, and production of their interactions with the protein at atomic level, respectively. Active compounds were found to be non-cytotoxic against mouse fibroblast (3T3) cell line MTT assay. Present study thereby identifies new inhibitors of urease enzyme in vitro as leads for further investigation towards the development of novel mechanism-based urease inhibitors.


Urease inhibition Ligand-based screening STD-NMR Molecular docking Urolithiasis 



This project was funded by the Deanship of Scientific Research (DSR) at the King Abdulaziz University, Jeddah, Saudi Arabia, under grant no. (21-130-35-RG). The authors, therefore, acknowledge with thanks DSR for technical, and financial support.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.

Supplementary material

44_2017_1945_MOESM1_ESM.pdf (1.4 mb)
Supplementary Information


  1. Amin M, Anwar F (2012) Green synthesis of silver nanoparticles through reduction with Solanum xanthocarpum L. berry extract: Characterization, antimicrobial and urease inhibitory activities against Helicobacter pylori. Int J Mol Sci 13:9923–9941CrossRefPubMedPubMedCentralGoogle Scholar
  2. Amtul Z, Atta-ur-Rahman, Siddiqui RA, Choudhary MI (2002) Chemistry and mechanism of urease inhibition. Curr Med Chem 9:1323–1348CrossRefPubMedGoogle Scholar
  3. Arfan M, Ali M, Ahmad H, Anis I, Khan A, Choudhary MI, Shah MR (2010) Urease inhibitors from Hypericum oblongifolium Wall. J Enzyme Inhib Med Chem 25:296–299CrossRefPubMedGoogle Scholar
  4. Atia-tul-Wahab, Khan A, Marasini BP, Lodhi MA, Atta-ur-Rahman, Choudhary MI (2013) Discovery and study of the bindingepitopes of novel urease inhibitors by STD-NMR spectroscopy and biochemical analyses. Lett Drug Des Discov 10:515–521Google Scholar
  5. Awllia JAJ, AL-Ghamdi M, Huwait E, Javaid S, Atia-tul-Wahab, Rasheed S, Choudhary MI (2015) Flavonoids as natural inhibitors of jack bean urease Enzyme. Lett Drug Des Discov 13:243–249CrossRefGoogle Scholar
  6. Balasubramanian A, Ponnuraj K (2010) Crystal structure of the first plant urease from Jack bean: 83 years of journey from its first crystal to molecular structure. J Mol Biol 400:274–283CrossRefPubMedGoogle Scholar
  7. Blaser MJ (1990) Helicobacter pylori and the pathogenesis of gastro duodenal inflammation. J Infect Dis 161:626–633CrossRefPubMedGoogle Scholar
  8. Chen Y, Liao J, Chen M, Huang Q, Lu Q (2015) Gossypol: New class of urease inhibitors, molecular docking and inhibition assay. J Chem Pharm Res 7(1):10–15Google Scholar
  9. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shaw DE, Shelley M, Perry JK, Francis P, Shenkin PS (2004) Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739–1749CrossRefPubMedGoogle Scholar
  10. Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein–ligand complexes. J Med Chem 49:6177–6196CrossRefPubMedGoogle Scholar
  11. Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL (2004) Glide: A new approach for rapid, accurate docking and scoring. 2. Chapter 1: introduction 6 Schrödinger software release 2015-4 enrichment factors in database screening. J Med Chem 47:1750–1759CrossRefPubMedGoogle Scholar
  12. Hameed A, Anwar A, Khan KM, Malik R, Shahab F, Siddiq S, Basha FZ, Choudhary MI (2013) Urease inhibition and anticancer activity of novel polyfuntional 5,6-dihydropyrimidine derivatives and their structure–activity relationship. Eur J Chem 4:49–52CrossRefGoogle Scholar
  13. Khan KM, Ali M, Wadood A, Zaheer-ul-Haq, Khan M, Lodhi MA, Perveen S, Choudhary MI, Voelter W (2011) Molecular modeling-based antioxidant arylidene barbiturates as urease inhibitors. J Mol Graph Model 30:153–156CrossRefPubMedGoogle Scholar
  14. Khan KM, Rahim F, Khan A, Taha M, Saad SM, Ali S, Khan M, Najeebullah, Shaikh A, Perveen S, Choudhary MI (2015) Synthesis of benzophenone hydrazone analogs and their DPPH radical scavenging, and urease inhibitory activities. J Chem Soc Pak 37:157–161Google Scholar
  15. Khan KM, Ullah Z, Lodhi MA, Ali M, Choudhary MI, Atta-ur-Rahman, Haq ZU (2006) Successful computer guided planned synthesis of (4R)-thiazolidine carboxylic acid and its 2-substituted analogues as urease inhibitors. Mol Divers 10:223–231CrossRefPubMedGoogle Scholar
  16. Khan MH, Hameed S, Yasin KA, Akhtar T, Khan KM (2010) Design, synthesis, and urease inhibition studies of some of 4-amino-5-aryl-3H-1,2,4-triazole-3-thione. Monatsh Chem 14:479–484CrossRefGoogle Scholar
  17. Kosikowska P, Berlicki L (2011) Urease inhibitors as potential drugs for gastric and urinary tract infections: A patent review. Expert Opin Ther Pat 21:945–957CrossRefPubMedGoogle Scholar
  18. Macegoniuk K (2013) Inhibitors of bacterial and plants urease. A review. Folia Biologica et Oecologica 9:9–16CrossRefGoogle Scholar
  19. Mayer M, Meyer B (2001) Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J Am Chem Soc 123:6108–6117CrossRefPubMedGoogle Scholar
  20. Meng X-Y, Zhang H-X, Mezei M, Cui M (2011) Molecular docking: A powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des 7:146–157CrossRefPubMedPubMedCentralGoogle Scholar
  21. Mobley HL, Hausinger RP (1998) Microbial ureases: significance, regulation, and molecular characterization. Microbiol Rev 53:85–108Google Scholar
  22. Modolo LV, de Fatima A, França MGC, Horta LP, Faria CVN, da Silva DL, Morais VSS (2013) National Institute for industrial property (INPI), Patent # BR1020130173568, BrazilGoogle Scholar
  23. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63CrossRefPubMedGoogle Scholar
  24. Olsson MH, Søndergard CR, Rostkowski M, Jensen JH (2011) Propka3: Consistent treatment of internal and surface residues in empirical pKa predictions. J Chem Theory Comput 7:525–537CrossRefPubMedGoogle Scholar
  25. Romero V, Akpinar H, Assimos DG (2010) Kidney stones: A global picture of prevalence, incidence, and associated risk factors. Rev Urol 12:e86–e96PubMedPubMedCentralGoogle Scholar
  26. Sastry GM, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27:221–234CrossRefPubMedGoogle Scholar
  27. Schrödinger (2015a) LigPrep, version 3.6, LLC, New York, NYGoogle Scholar
  28. Schrödinger (2015b) LLC, New York, NY. Glide, version 6.9Google Scholar
  29. Schrödinger (2015c) Prime, version 4.2, LLC, New York, NY.Google Scholar
  30. Schrödinger (2015d) Protein Preparation Wizard 2015-4; Epik version 2.4, Schrödinger, LLC, New York, NY, 2015; Impact version 5.9, Schrödinger, LLC, New York, NY, 2015; Prime version 3.2, Schrödinger, LLC, New York, NY, 2015Google Scholar
  31. Scopes RK (2002) Enzyme activity and assays. eLSGoogle Scholar
  32. Shahzad SA, Yar M, Khan ZA, Khan IU, Naqvi SAR, Mahmood N, Khan KM (2012) Microwave-assisted solvent free efficient synthesis of 1,3,4-oxazole-2(3H)-thiones and their in vitro urease inhibitory activity. Eur J Chem 3:143–146CrossRefGoogle Scholar
  33. Taleb-Contini SH, Salvador MJ, Watanabe E, Ito IY, de Oliveira DCR (2003) Antimicrobial activity of flavonoids and steroids isolated from two Chromolaena species. Braz J Pharm Sci 39(4):403–408Google Scholar
  34. Thadhani VM, Khan A, Atia-tul-Wahab, Javaid S, Shafqat A, Zaheer-ul-Haq, Choudhary MI (2015) Study of binding epitopes by STD-NMR spectroscopy and molecular docking of urease inhibitors from lichens. Lett Drug Des Discov 13:282–294CrossRefGoogle Scholar
  35. Weatherburn MW (1967) Phenol-hypochlorite reaction for determination of ammonia. Anal Chem 39:971–974CrossRefGoogle Scholar
  36. Yu-Sen W, Dingjiang L, Daniel FW (2004) Competition STD NMR for the detection of high-affinity ligands and NMR-based screening. Magn Reson Chem 42:485–489CrossRefGoogle Scholar
  37. Zhang L, Mulrooney SB, Leung AF, Zeng Y, Ko BB, Hausinger RP, Sun H (2006) Inhibition of urease by bismuth (III): Implications for the mechanism of action of bismuth drugs. BioMetals 19:503–511CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Jalaluddin A. Khan
    • 1
  • Atia-tul- Wahab
    • 2
  • Sumaira Javaid
    • 3
  • Maryam AL-Ghamdi
    • 1
  • Etimad Huwait
    • 1
  • Muniza Shaikh
    • 2
  • Amsal Shafqat
    • 2
  • M. Iqbal Choudhary
    • 1
    • 2
    • 3
    Email author
  1. 1.Department of Biochemistry, Faculty of ScienceKing Abdulaziz UniversityJeddah-22254Saudi Arabia
  2. 2.Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center of Chemical and Biological SciencesUniversity of KarachiKarachi-75270Pakistan
  3. 3.H. E. J. Research Institute of Chemistry, International Center for Chemical and Biological SciencesUniversity of KarachiKarachi-75270Pakistan

Personalised recommendations